Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:II-50-II-54
doi: 10.1161/01.CIR.0000143121.71433.05
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kettelkamp, R.
Right arrow Articles by Spertus, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kettelkamp, R.
Right arrow Articles by Spertus, J.
Related Collections
Right arrow Restenosis
Right arrow Catheter-based coronary interventions: stents
Right arrow CV surgery: coronary artery disease

(Circulation. 2004;110:II-50 – II-54.)
© 2004 American Heart Association, Inc.


Surgery for Coronary Artery Disease

Using the Risk of Restenosis as a Guide to Triaging Patients Between Surgical and Percutaneous Coronary Revascularization

Richard Kettelkamp, DO MHA; John House, MS; Mukesh Garg, MD; R. Scott Stuart, MD; Aaron Grantham, MD; John Spertus, MD MPH

From Mid America Heart Institute of Saint Luke’s Hospital and the University of Missouri–Kansas City, Kansas City, Mo.

Correspondence to Richard Kettelkamp, DO, MHA Mid America Heart Institute, 5th Floor Saint Luke’s Hospital, 4100 Wornall Road, Kansas City, MO 64111. E-mail kettelkampd{at}umkc.edu

Background— Coronary artery bypass graft (CABG) and percutaneous coronary revascularization (PCI) are strategies for treating coronary disease. Because the principal limitation of PCI is restenosis, CABG might be favored for those at high risk for restenosis. Using a clinical risk score for predicting restenosis, we examined whether patients with higher risks for restenosis were preferentially referred for CABG.

Methods and Results— A procedural registry of 2320 revascularization patients from whom data on procedure type, demographics, comorbid conditions, health status, vessel anatomy, and outcomes were taken was analyzed. Patients were classified and scored into 3 categories of restenosis risk ranging from 11% to 44%, as defined by 8 preprocedural characteristics. The objective of this study was to describe referral patterns between PCI and CABG in each category of risk. 2060 patients underwent nonemergent revascularization. 1404 of the patients underwent PCI and 656 were treated with CABG. Among the patients at low and intermediate risk for restenosis, twice as many were referred to PCI. Among those at the highest risk, 3-times as many were referred to PCI, resulting in a significant trend for those with the higher risks of restenosis to be preferentially referred to PCI (P=0.015). Similar results were seen when the analysis was restricted to only those with multivessel disease.

Conclusions— Patients at higher risk for restenosis were being preferentially treated with PCI as opposed to CABG. These results may have implications for reevaluating current patterns of triaging patients between PCI and CABG, and for the use of drug-eluting stents within PCI patients.


Key Words: bypass • angioplasty • restenosis • atherosclerosis